CASI PHARMACEUTICALS, INC. (CASIF) Net margin 2020–2025
CASI PHARMACEUTICALS, INC. (CASIF) net profit margin by fiscal year — reported net income divided by reported revenue.
-232.0%FY2025 · since FY2020: -321.9% → -232.0%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -232.0% | -94.5 pp |
| FY2024 | -137.6% | -58.0 pp |
| FY2023 | -79.6% | +28.2 pp |
| FY2022 | -107.8% | +14.3 pp |
| FY2021 | -122.1% | +199.8 pp |
| FY2020 | -321.9% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More CASIF financial trends
CASIF RevenueCASIF Net incomeCASIF Gross profitCASIF Gross marginCASIF Operating incomeCASIF Operating marginCASIF Operating cash flowCASIF Free cash flowCASIF Capital expendituresCASIF Return on equityCASIF Stock buybacksCASIF Dividends paidCASIF Total assetsCASIF Total liabilitiesCASIF Shareholders’ equityCASIF overview →